Publications by authors named "Aaron L Boster"

Claim this Profile
A
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years.
Ann D Bass, Rafael Arroyo, Aaron L Boster, Alexey N Boyko, Sara Eichau

Mult Scler Relat Disord· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial.
Alasdair J Coles, Douglas L Arnold, Ann D Bass, Aaron L Boster, D Alastair S Compston

Ther Adv Neurol Disord· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
Giancarlo Comi, Raed Alroughani, Aaron L Boster, Ann D Bass, Regina Berkovich

Mult Scler· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management.
Aaron L Boster, Roy L Adair, Judith L Gooch, Mary Elizabeth S Nelson, Andrea Toomer

Neuromodulation· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practices for Intrathecal Baclofen Therapy: Screening Test.
Aaron L Boster, Susan E Bennett, Gerald S Bilsky, Mark Gudesblatt, Stephen F Koelbel

Neuromodulation· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practices for Intrathecal Baclofen Therapy: Patient Selection.
Michael Saulino, Cindy B Ivanhoe, John R McGuire, Barbara Ridley, Jeffrey S Shilt, Aaron L Boster

Neuromodulation· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practices for Intrathecal Baclofen Therapy: Troubleshooting.
Michael Saulino, David J Anderson, Jennifer Doble, Reza Farid, Fatma Gul, Aaron L Boster

Neuromodulation· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.
Jacqueline Ann Nicholas, Aaron Lee Boster, Jaime Imitola, Colleen O'Connell, Michael Karl Racke

Drug Des Devel Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.
Aaron L Boster, Corey C Ford, Orit Neudorfer, Yossi Gilgun-Sherki

Expert Rev Neurother· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration.
Joshua C Orack, Michela Deleidi, David Pitt, Kedar Mahajan, Jacqueline A Nicholas, Aaron L Boster

Stem Cells Transl Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
Jacqueline Ann Nicholas, Michael Karl Racke, Jamie Imitola, Aaron Lee Boster

Ther Adv Chronic Dis· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis: Five new things.
Jacqueline A Nicholas, Aaron L Boster, Michael K Racke

Neurol Clin Pract· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
Aaron L Boster, Jacqueline A Nicholas, Ilir Topalli, Yaz Y Kisanuki, Wei Pei

JAMA Neurol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric-onset multiple sclerosis in African-American black and European-origin white patients.
Aaron L Boster, Christina F Endress, Stephanie A Hreha, Christina Caon, Jai S Perumal

Pediatr Neurol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis